健康元药业集团研发的抗流感1类创新药——玛帕西沙韦胶囊(壹立康®)即将在阿里健康线上首发。该药是我国自主研发、获批上市的新型帽依赖性核酸内切酶抑制剂,用于治疗12周岁及以上单纯性甲型和乙型流感患者,以其“全程仅需单次口服”的突出治疗便利性备受关注。届时,用户在淘宝APP搜索“壹立康”,即可便捷获取相关药品信息与专业用药咨询。冬季是流感高发的季节。国家卫生健康委近期召开的新闻发布会中提到,当前全国...
Source Link健康元药业集团研发的抗流感1类创新药——玛帕西沙韦胶囊(壹立康®)即将在阿里健康线上首发。该药是我国自主研发、获批上市的新型帽依赖性核酸内切酶抑制剂,用于治疗12周岁及以上单纯性甲型和乙型流感患者,以其“全程仅需单次口服”的突出治疗便利性备受关注。届时,用户在淘宝APP搜索“壹立康”,即可便捷获取相关药品信息与专业用药咨询。冬季是流感高发的季节。国家卫生健康委近期召开的新闻发布会中提到,当前全国...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.